Pacific Biosciences of California, Inc. is a global life sciences technology company headquartered in Menlo Park, California, that develops genetic sequencing systems.
Subscribe to see Pacific Biosciences of California, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pacific Biosciences of California, Inc. is a biotechnology company headquartered in Menlo Park, United States. It is publicly listed (PACB) with a market capitalisation of $723.7M. Xcout tracks 18 named people at Pacific Biosciences of California, Inc., including Mark Van Oene (CEO, President & Director). Xcout recorded 22 job postings from Pacific Biosciences of California, Inc. in the last 90 days, naming tools such as SAP.
12 more named people on record for Pacific Biosciences of California, Inc., with roles, board committees and tenure — see the full roster →
Xcout recorded 22 job postings from Pacific Biosciences of California, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Pacific Biosciences of California, Inc.'s hiring signals →
4 corporate events on record, with sources — see the full timeline →
A few of Pacific Biosciences of California, Inc.'s closest competitors — see the full list of competitors and alternatives →
Apton Biosystems, Inc. is a Bay Area-based life sciences company that developed high-throughput short-read genetic sequencers utilizing advanced optics, prior to its acquisition agreement with PacBio.
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
Phase Genomics, Inc. is headquartered in Seattle, Washington, and provides ultra-long-range sequencing solutions and Hi-C technologies. The company supports genomic research and applications through its specialized laboratory products and services.
Oxford Nanopore Technologies plc is a UK-based company which develops and sells nanopore sequencing products for the direct, electronic analysis of single molecules. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Twist Bioscience Corp is headquartered in South San Francisco, California, and operates in the synthetic biology sector. The company manufactures and sells customized DNA synthesis products utilizing a silicon-based platform for various scientific applications.
Illumina, Inc. specializes in delivering advanced sequencing and array technologies designed for genetic and genomic examination. These offerings cater to a diverse array of markets, fostering the widespread use of genomic insights across both research laboratories and clinical environments. Key application areas include life sciences, cancer diagnostics, reproductive medicine, agricultural science, and various nascent fields. The company's portfolio encompasses specialized instrumentation and associated consumables vital for genetic analysis. Additionally, it offers comprehensive genotyping and sequencing services, extends instrument maintenance contracts, and engages in development and licensing partnerships, alongside providing cancer screening services. Illumina's client base is extensive, comprising genomic research facilities, universities, state-funded laboratories, and healthcare providers. It also serves pharmaceutical firms, biotechnology companies, commercial molecular diagnostics providers, and businesses focused on consumer genomics. Globally, Illumina distributes its products through direct sales channels in North America, Europe, Latin America, and the Asia-Pacific. Furthermore, it leverages third-party life-science distributors to reach markets across Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.